申请人:Intellikine LLC
公开号:US20190350906A1
公开(公告)日:2019-11-21
Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.